FluidForm to Develop New 3D Bioprinting Solutions for J&J Bioprinting

FluidForm to Develop New 3D Bioprinting Solutions for J&J Bioprinting

FluidForm, an expert in the field of human tissue for research, repair, and replacement signed an agreement with Ethicon, a member of the Johnson & Johnson Medical Devices Companies, to develop 3D bioprinted applications using FluidForm’s patented FRESH technology. This collaboration leverages FluidForm’s FRESH 3D bioprinting platform to achieve specific tissue characteristics that cannot be manufactured with conventional techniques.

3D-Printed Microneedles for Continuous Glucose Monitoring

3D-Printed Microneedles for Continuous Glucose Monitoring

For many of the 422 million people around the world living with diabetes, glucose monitoring is a necessary, and uncomfortable, daily chore requiring a painful pinprick to test the blood. Newer technologies, like the FreeStyle Libre, offer continuous monitoring, but the system still requires that a 5mm rigid metallic needle be driven into the skin. While not as bothersome as the fingertip lance, it’s still uncomfortable for the patient. Aiming to develop a solution that’s more comfortable for the user, the AIT – Austrian Institute of Technology – partnered with DirectSens and In-Vision to launch the NUMBAT research project. NUMBAT aims at leveraging high-resolution DLP 3D printing to create an array of polymeric microneedles for minimally invasive—and less painful—continuous glucose monitoring (CGM).

Stratasys Introduces All-In-One J5 MediJet Medical 3D Printer

Stratasys Introduces All-In-One J5 MediJet Medical 3D Printer

Stratasys introduced a medical 3D printer that sets a new standard for healthcare providers and medical device companies by combining multiple applications in one system. With multiple materials and multi-color capabilities, the Stratasys J5 MediJet 3D printer enables users to create highly detailed 3D anatomical models and drilling and cutting guides with approved third-party 510k-cleared segmentation software. Guides and models are certified as sterilizable and biocompatible, and the printer is economical and compact enough for small lab spaces.

Materialise Kickstarts the New Generation of Custom AM Insoles

Materialise Kickstarts the New Generation of Custom AM Insoles

The Materialise Phits Suite is a new standard of personalized care program that helps improve patient mobility. After decades of experience in gait analysis and 3D technology, Materialise wants to start the next generation of insoles, leveraging the latest digital path capture technology, advanced analysis software and 3D printing to achieve a more accurate, efficient and fully customizable workflow. The Materialise Phits Suite is a digital toolbox for accurate and efficient end-to-end workflow, that can assist in providing patient counseling, care, and treatment.